-+ 0.00%
-+ 0.00%
-+ 0.00%

Opaleye Management reports $24,200 purchase of Grace Therapeutics shares

PUBT·08/19/2026 11:45:24
Listen to the news
Opaleye Management reports $24,200 purchase of Grace Therapeutics shares
  • Opaleye Management, led by President James Silverman, bought 11,608 Grace Therapeutics common shares at a weighted average USD 2.09.
  • Opaleye’s indirect stake, held through Opaleye, L.P., rose to 2.76 million shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grace Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-039124), on August 19, 2026, and is solely responsible for the information contained therein.